These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29739413)

  • 1. The role of HIV Tat protein in HIV-related cardiovascular diseases.
    Jiang Y; Chai L; Fasae MB; Bai Y
    J Transl Med; 2018 May; 16(1):121. PubMed ID: 29739413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Tat Upregulates the Receptor for Advanced Glycation End Products and Superoxide Dismutase-2 in the Heart of Transgenic Mice.
    Qrareya AN; Wise NS; Hodges ER; Mahdi F; Stewart JA; Paris JJ
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat.
    Wang T; Yi R; Green LA; Chelvanambi S; Seimetz M; Clauss M
    Cardiovasc Pathol; 2015; 24(5):279-82. PubMed ID: 26233281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of HIV-1 TAT protein and methamphetamine exposure on visual discrimination and executive function in mice.
    Kesby JP; Fields JA; Chang A; Coban H; Achim CL; Semenova S;
    Behav Brain Res; 2018 Sep; 349():73-79. PubMed ID: 29709610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in Research and Application of HIV-1 TAT-Derived Cell-Penetrating Peptide.
    Zou L; Peng Q; Wang P; Zhou B
    J Membr Biol; 2017 Apr; 250(2):115-122. PubMed ID: 27933338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders.
    Zucchini S; Pittaluga A; Brocca-Cofano E; Summa M; Fabris M; De Michele R; Bonaccorsi A; Busatto G; Barbanti-Brodano G; Altavilla G; Verlengia G; Cifelli P; Corallini A; Caputo A; Simonato M
    Neurobiol Dis; 2013 Jul; 55():110-9. PubMed ID: 23454193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Tat enhances replicative potential of human oral keratinocytes harboring HPV-16 genome.
    Kim RH; Yochim JM; Kang MK; Shin KH; Christensen R; Park NH
    Int J Oncol; 2008 Oct; 33(4):777-82. PubMed ID: 18813791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.
    Hahn YK; Paris JJ; Lichtman AH; Hauser KF; Sim-Selley LJ; Selley DE; Knapp PE
    Neurobiol Dis; 2016 Aug; 92(Pt B):124-36. PubMed ID: 26845176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to HIV-1 Tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice.
    Paris JJ; Singh HD; Carey AN; McLaughlin JP
    Behav Brain Res; 2015 Sep; 291():209-218. PubMed ID: 26005128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tat/P-TEFb Protein-Protein Interaction Determining Transcriptional Activation of HIV.
    Asamitsu K; Okamoto T
    Curr Pharm Des; 2017; 23(28):4091-4097. PubMed ID: 28699519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV Tat protein: Is Tat-C much trickier than Tat-B?
    Johri MK; Sharma N; Singh SK
    J Med Virol; 2015 Aug; 87(8):1334-43. PubMed ID: 25879536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of HIV-1 Tat-Associated Proteins Contributing to HIV-1 Transcription and Latency.
    Jean MJ; Power D; Kong W; Huang H; Santoso N; Zhu J
    Viruses; 2017 Apr; 9(4):. PubMed ID: 28368303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.
    Gonek M; McLane VD; Stevens DL; Lippold K; Akbarali HI; Knapp PE; Dewey WL; Hauser KF; Paris JJ
    Brain Behav Immun; 2018 Mar; 69():124-138. PubMed ID: 29146238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
    Demberg T; Florese RH; Heath MJ; Larsen K; Kalisz I; Kalyanaraman VS; Lee EM; Pal R; Venzon D; Grant R; Patterson LJ; Korioth-Schmitz B; Buzby A; Dombagoda D; Montefiori DC; Letvin NL; Cafaro A; Ensoli B; Robert-Guroff M
    J Virol; 2007 Apr; 81(7):3414-27. PubMed ID: 17229693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super elongation complex promotes early HIV transcription and its function is modulated by P-TEFb.
    Kuzmina A; Krasnopolsky S; Taube R
    Transcription; 2017 May; 8(3):133-149. PubMed ID: 28340332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV Tat Impairs Neurogenesis through Functioning As a Notch Ligand and Activation of Notch Signaling Pathway.
    Fan Y; Gao X; Chen J; Liu Y; He JJ
    J Neurosci; 2016 Nov; 36(44):11362-11373. PubMed ID: 27807176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline.
    Kim BO; Liu Y; Ruan Y; Xu ZC; Schantz L; He JJ
    Am J Pathol; 2003 May; 162(5):1693-707. PubMed ID: 12707054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
    Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
    BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tat-induced lesions in transgenic mice do not correlate with the HIV-1 LTR transactivation.
    Fergelot P; Molina T; Blanchet P; Grimber G; Duquenne O; Couton D; Zider A; Briand P; Cavard C
    C R Acad Sci III; 1995 Mar; 318(3):329-37. PubMed ID: 7788501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.